Two good reasons for an angiotensin-II type 1 receptor blockade with losartan after cardiac transplantation: Reduction of incidence and severity of transplant vasculopathy

Transplant International

Volumn 16, Issue 1, 2003, Pages 26-32

  Richter, Markus H C ^a,b   Richter, Heike R ^a   Olbrich, Hans Georg ^a,c   Mohr, Friedrich Wilhelm ^b  

^a Experimental Heart Transplant Group   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c St Barbara Hospital   (Germany)

Author keywords

Angiotensin converting enzyme; AT1 receptor blockade; Renin angiotensin system; Transplant vasculopathy

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOSARTAN;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL OCCLUSION; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; GRAFT REJECTION; GRAFT SURVIVAL; HEART GRAFT; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTIMA; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT; RECIPIENT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOOTH MUSCLE FIBER; STATISTICAL SIGNIFICANCE; TRANSPLANT VASCULOPATHY; TREATMENT INDICATION; TREATMENT OUTCOME; VALIDATION PROCESS; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

ACUTE DISEASE; ANIMALS; ANTIHYPERTENSIVE AGENTS; CORONARY ARTERIOSCLEROSIS; CYCLOSPORINE; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; LOSARTAN; MODELS, ANIMAL; POSTOPERATIVE COMPLICATIONS; RATS; RATS, INBRED F344; RATS, INBRED LEW; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; SEVERITY OF ILLNESS INDEX;

EID: 0038278881     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2003.tb00219.x     Document Type: Article

References (41)

1. Adams DH, Tilney NL, Collins IJ, Karnowsky MJ (1992) Experimental graft arteriosclerosis. I. The Lewis-to-Fischer F344 allograft model. Transplantation 53:1115-1119
2. Alexander RW, Gimbrone MAJ (1976) Stimulation of prostaglandin E synthesis cultured in human umbilical vein smooth muscle cells. Proc Natl Acad Sci U S A 73:1617-1620
3. Balcells E, Meng QC, Johnson WH Jr, Oparil S, Dell'Italia LJ (1997) Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species consideration. Am J Physiol 273:H1769-H1774
4. 1 receptor expression and angiotensin II concentrations after long-term blockade of the renin-angiotensin system in cardiomyopathic hamsters. J Cardiovasc Pharmacol 34:402-406
5. Berridge MJ, Irvine RF (1998) Inositol phosphatases and cell signaling. Nature 341:197-205
6. Billingham ME, Cary NR, Hammond ME, Kemnitz J, Marboe C, McCallister HA, Snovar DC, Winters GL, Zerbe A (1990) A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection. Heart Rejection Study Group. J Heart Transplant 9:587-593
7. De Nucci G, Warner T, Vane JR (1988) Effect of captopril on the bradykinin-induced release of prostacyclin from guinea pig lung or bovine aortic endothelial cell. Br J Pharmacol 95:783-788
8. Diet F, Pratt RR, Berry GJ, Momose N, Gibbons GH, Dzau VJ (1996) Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 94:2756-2767
9. Dubey RK, Jackson EK, LûYscher TF (1995) Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell: role of cyclic-nucleotides and angiotensin I receptor. J Clin Invest 96:141-149
10. Dzau VJ (1993) Local expression and pathobiological role of renin-angiotensin in the blood vessels and heart. Basic Res Cardiol 1:1-14
11. Ehlers MRW, Riordan JF (1989) Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry 28:5311-5318
12. Farhy RD, Carretero OA, Ho KL, Scicli AG (1993) Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res 72:1202-1210
13. Grûflfe M, Auch-Schwelk W, Zakrzewicz A, Regitz-Zagrosek V, Bartsch P, Graf K, Loebe M, Gaehtgens P, Fleck E (1997) Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin. Circ Res 81:804-811
14. Inagami T, Guo DF, Kitami Y (1994) Molecular biology of angiotensin II receptors: an overview. J Hypertens Suppl 12:S83-S94
15. Janiak P, Pillon A, Prost JF, Vilaine JP (1992) Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension 20:737-745
16. Jard S, Cantau B, Jacobs KH (1981) Angiotensin II and o-adrenergic agonists inhibit liver adenylate cyclase. J Biol Chem 256:2603-2606
17. Jelsema CL, Moss J, Manganiello VC (1985) Effect of bradykinin on prostaglandin production by human skin fibroblasts in culture. Methods Enzymol 109:480-503
18. Johnson DE, Gao SZ, Schroeder JS, DeCampli WM, Billingham ME (1989) The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Transplant 8:349-359
19. Johnston CI (2000) Angiotensin II type 1 receptor blockade: a novel therapeutic concept. Blood Press Suppl 1:9-13
20. Kauffman RF, Bean JS, Zimmerman KM, Brown RF, Steinberg MI (1991) Losartan, a nonpeptide angiotensin II (Ang II) receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries. Life Sci 49:PL223-PL228
21. Kim S, Izumi Y, Yano M, Hamaguchi A, Miura K, Yamanaka S, Miyazaki H, Iwao H (1998) Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery. Circulation 97:1731-1737
22. Kitami Y, Okura T, Marumoto K, Wakamiya R, Hiwada K (1992) Differential gene expression and regulation of type 1 angiotensin II receptor subtypes in the rat. Biochem Biophys Res Commun 188:446-452
23. Kobayashi J, Crawford SE, Backer CL, Zales VR, Takami H, Hsueh C, Huang C, Mavroudis C (1993) Captopril reduces graft coronary artery disease in a rat heterotopic transplant model. Circulation 88:1286-1290
24. Lassegue B, Alexander RW, Clark M, Griendling KK (1991) Angiotensin II-induced phosphatidylcholine hydrolysis in cultured vascular smooth muscle cells. Regulation and localization. Biochem J 276:19-25
25. Liao DF, Duff JL, Daum G, Pelech SL, Berk BC (1996) Angiotensin II stimulates MAP kinase activity in vascular smooth muscle cells, role of Raf. Circ Res 97:1007-1014
26. Naftilan AJ, Ryan TJ, Pratt RE, Dzau VJ (1991) Localization and differential regulation of angiotensinogen mRNA expression in the vessel wall. J Clin Invest 87:1300-1311
27. Needleman P, Marshall GR, Sobel BE (1975) Hormone interaction in the isolated rabbit heart. Synthesis and coronary vasomotor effects of prostaglandins, angiotensin, and bradykinin. Circ Res 37:802-808
28. Neish AS, Loh E, Schoen FJ (1992) Myocardial changes in cardiac transplant-associated coronary arteriosclerosis: potential for timely diagnosis. J Am Coll Cardiol 19:586-592
29. Ono K, Lindsey ES (1969) Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 547:225-228
30. Pascoe EA, Barnhart GR, Carter WH Jr, Thompson JA, Hess ML, Hastillo A, Szentpetery S, Lower RR (1991) The prevalence of cardiac allograft arteriosclerosis. Transplantation 44:838-839
31. Powell JS, Clozel JP, MûYller RKM, Kuhn H, Hefti F, Hosang M, Baumgartner HR (1989) Inhibitors of the angiotensin-converting enzyme prevent myointimal injury after vascular injury. Science 245:186-188
32. Rakugi H, Duk-Kyung K, Krieger JE, Wang DS, Dzau VJ, Pratt RE (1994) Induction of angiotensin-converting enzyme in the neointima after vascular injury: possible role in restenosis. J Clin Invest 93:339-346
33. Richter M, Richter H (2000) Heart transplantation in rats. In: Radacic M, Basic I, Eljuga D (eds) Pokusni modeli u biomedicini. Medicinska Naklada, Zagreb, pp 37-51
34. Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809
35. Smith JB (1986) Angiotensin-receptor signaling in cultured vascular smooth muscle cells. Am J Physiol 250:F759-F769
36. Su E, Lombardi DM, Siegal J, Schwartz SM (1998) Angiotensin II induces vascular smooth muscle cell replication independent of blood pressure. Hypertension 31:1331-1337
37. Szabo A, Lutz J, Schleimer K, Antus B, Hamar P, Philipp T, Heemann U (2000) Effect of angiotensin-converting enzyme inhibitors on growth factor mRNA in chronic allograft rejection in the rat. Kidney Int 57:982-991
38. Urata H, Boehm KD, Philip A, Kinoshita A, Gabrovsek J, Bumpus FM (1993) Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 91:1269-1281
39. Van Kesteren CA, van Heugten HA, Lamers JM, Saxena PR, Schalekamp MA, Danser AH (1997) Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts. J Mol Cell Cardiol 29:2147-2157
40. 1 receptors in neointima of the rat aorta. J Clin Invest 90:1707-1712
41. Weinstock JV, Blum AM, Kassab JT (1987) Angiotensin II is chemotactic for a T-cell subset which can express migration inhibition factor activity in murine schistosomiasis mansoni. Cell Immunol 107:180-187